Mode
Text Size
Log in / Sign up
N/A N=44 Randomized Treatment

Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia

Social Anxiety Disorder

Enrolled (actual)
44
Serious AEs
Results posted
May 2025
Primary outcome: Primary: Change From Baseline in the Social Phobia Diagnostic Questionnaire (SPDQ) at Post-treatment — -9.60; -4.46 score on a scale — p=< 0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Pico Goblin VR headset (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Penn State University
Primary completion
Dec 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline in the Social Phobia Diagnostic Questionnaire (SPDQ) at Post-treatment
-9.60; -4.46 < 0.05 sig
PRIMARY
Change From Baseline in the Social Interaction Anxiety Scale (SIAS) at Post-treatment
-28.19; -16.65 < 0.05 sig
SECONDARY
Change From Baseline in the Measure of Anxiety in Selection Interviews (MASI) at Post-treatment
-36.52; -22.57 < 0.05 sig
SECONDARY
Change From Baseline in the Penn State Worry Questionnaire (PSWQ) at Post-treatment
-21.18; -13.10 < 0.05 sig
SECONDARY
Change From Baseline in the Patient Health Questionnaire (PHQ-9) at Post-treatment
-6.74; -3.26 > 0.05

Summary

The purpose of this study is to test the efficacy virtual reality videos to facilitate exposure therapy in social anxiety disorder (SAD). The exposure therapy videos are the focus of this experiment. Essentially, we are testing the efficacy of the Virtual Reality Exposure Therapy (VRET) scripts (i.e., virtual scenarios, people, and interactions that we expose socially anxious people to). To this end, the goal of the current study is to help people with social anxiety overcome their phobias. Individuals who experience a difficult time building social relationships, accomplishing everyday tasks, or pursuing job interviews can practice those same behaviors in a controlled environment. Specifically, we aim to test the following hypotheses: (1) Virtual reality exposure therapy intervention (vs. waitlist control condition) is effective for treating SAD symptoms. (2) Participants who received the VRET will experience maintenance of treatment gains following 3-month and 6-month post-termination of treatment. (3) Users of the virtual reality exposure therapy will demonstrate high amounts of acceptability of the treatment.

Eligibility Criteria

Inclusion Criteria

  • Presence of Social Anxiety Disorder based on the Social Phobia Diagnostic Questionnaire self-report or Mini International Neuropsychiatric Interview
  • Current student at the Pennsylvania State University or a community-dwelling adult who expressed interest to participate through the PSU StudyFinder portal
  • Expressed interest to seek treatment
  • Currently not receiving treatment from a mental health professional
  • Able to provide consent
  • Proficient in English

Exclusion Criteria

  • Below age 18
  • Failure to meet any of above inclusion criteria
  • Presence of suicidality, mania, psychosis, or substance use disorders
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04850989). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search